Steris Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STERIS
STERIS has twelve approved drugs.
There are two US patents protecting STERIS drugs. There is one tentative approval on STERIS drugs.
There are two patent family members on STERIS drugs in two countries and eighty-five supplementary protection certificates in nine countries.
Summary for Steris
| International Patents: | 2 |
| US Patents: | 2 |
| Tradenames: | 9 |
| Ingredients: | 8 |
| NDAs: | 12 |
| Drug Master File Entries: | 21 |
Drugs and US Patents for Steris
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steriscience | VANCOCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 062716-001 | Mar 13, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Steriscience | VANCOCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 062812-002 | Nov 17, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Steriscience | ZIPRASIDONE MESYLATE | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 217595-001 | Sep 3, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Steriscience | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | POWDER;INTRAVENOUS | 215324-001 | Oct 2, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Steriscience | VANCOCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 062812-003 | Nov 17, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Steris Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2019221815 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2019221815 | ⤷ Start Trial |
| China | 112243376 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Steris Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2673237 | LUC00111 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; AUTHORISATION NUMBER AND DATE: EU/1/17/1173 20180326 |
| 0268956 | 1999C0030 | Belgium | ⤷ Start Trial | PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508 |
| 2340828 | LUC00195 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: SACUBITRIL ET VALSARTAN, SOUS FORME DE COMPLEXE DE SEL DE SODIUM SACUBITRIL VALSARTAN, C'EST-A-DIRE (((S)-N-VALERYL-N-((2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL)-METHYL)-VALINE) ((2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-ESTER ETHYLIQUE D'ACIDE PENTANOIQUE))NA3 X H2O, DANS LEQUEL X EST 0 A 3; AUTHORISATION NUMBER AND DATE: EU/1/15/1058 20151123 |
| 1758590 | 2017C/063 | Belgium | ⤷ Start Trial | PRODUCT NAME: SEL DE SODIUM D'ACIDE DESOXYCHOLIQUE; AUTHORISATION NUMBER AND DATE: SE/H/1547/01/DC 20170612 |
| 0473687 | SPC/GB98/030 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
